Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Two-part Proof-of-Concept Study Assessing the Safety and Efficacy of LAT8881 in Lumbar Radicular Pain

NCT05298306 is registered in ClinicalTrials.gov with Lateral Pharma Pty Ltd as lead sponsor.

NCT NCT05298306
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05298306 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Two-part Proof-of-Concept Study Assessing the Safety and Efficacy of LAT8881 in Lumbar Radicular Pain
Lead sponsor
Lateral Pharma Pty Ltd
Phase
Phase 1
Overall status
Completed
Start date
May 17, 2022
Completion date
June 16, 2023
Enrollment
26 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

radiculopathy lumbar